Watch our capabilities presentation to learn how our integrated CDMO solutions accelerate immune cell therapy development from early-phase to commercial readiness.
May 15, 2025 – Research Triangle Park, NC – Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring...
May 15, 2025 – Research Triangle Park, NC – Kincell Bio announced the completion of a $22 million round, led by a new investor, NewSpring...
Read MoreWatch our capabilities presentation to learn how our integrated CDMO solutions accelerate immune cell therapy development from early-phase to commercial readiness.
Preferred Partner Network (PPN) members will become Centers of Excellence for the IRO® platform combining best-in-class technology with industry-leading development and manufacturing capabilities. PHILADELPHIA and...
Read MoreMarch 17, 2025 (Research Triangle Park, NC): Kincell Bio, a leader in cell therapy development and manufacturing, is excited to announce the appointment of Larry...
Read MoreResearch Triangle Park, NC, Jaunary 20, 2025: Kincell Bio, a leader in cell therapy development and manufacturing, is excited to announce the appointment of Mark...
Read MoreExperienced commercial leader joins Kincell to support client solutions DURHAM, N.C.–(BUSINESS WIRE)–Kincell Bio, a leader in cell therapy development and manufacturing, is excited to announce...
Read More
1622 NW 55th Place
Gainesville, FL 32653
20 TW Alexander Dr, Suite 130
RTP, NC 27703
